Vetr upgraded shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) from a hold rating to a buy rating in a research report released on Thursday. They currently have $1,020.34 price target on the medical equipment provider’s stock.

A number of other brokerages have also recently weighed in on ISRG. BidaskClub cut shares of Intuitive Surgical from a buy rating to a hold rating in a report on Tuesday, August 1st. Barclays PLC raised their target price on shares of Intuitive Surgical from $870.00 to $1,000.00 and gave the stock an overweight rating in a report on Friday, July 21st. They noted that the move was a valuation call. Canaccord Genuity restated a hold rating and set a $870.00 target price on shares of Intuitive Surgical in a report on Tuesday, July 11th. Zacks Investment Research cut shares of Intuitive Surgical from a buy rating to a hold rating in a report on Wednesday, June 7th. Finally, J P Morgan Chase & Co restated an overweight rating and set a $1,050.00 target price on shares of Intuitive Surgical in a report on Friday, July 21st. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical has a consensus rating of Buy and a consensus price target of $980.61.

Shares of Intuitive Surgical (NASDAQ:ISRG) traded up 1.2381% during midday trading on Thursday, reaching $985.1475. The company’s stock had a trading volume of 239,928 shares. The stock has a 50 day moving average of $945.15 and a 200-day moving average of $842.09. The company has a market capitalization of $36.60 billion, a P/E ratio of 47.1859 and a beta of 0.39. Intuitive Surgical has a 1-year low of $610.71 and a 1-year high of $993.00. Intuitive Surgical’s stock is going to split before the market opens on Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly minted shares will be payable to shareholders after the market closes on Wednesday, August 30th.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.79 by $0.16. The business had revenue of $756.20 million during the quarter, compared to analysts’ expectations of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The business’s revenue was up 12.8% on a year-over-year basis. During the same period last year, the firm posted $5.62 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical will post $23.92 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/18/intuitive-surgical-inc-isrg-upgraded-by-vetr-inc-to-buy.html.

In related news, EVP Salvatore Brogna sold 1,306 shares of the company’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $915.09, for a total value of $1,195,107.54. Following the completion of the sale, the executive vice president now owns 977 shares in the company, valued at approximately $894,042.93. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 31st. The shares were sold at an average price of $917.27, for a total transaction of $917,270.00. Following the completion of the sale, the director now owns 3,787 shares of the company’s stock, valued at approximately $3,473,701.49. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,065 shares of company stock valued at $31,659,090. 2.50% of the stock is owned by insiders.

Large investors have recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America increased its stake in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the last quarter. ETF Managers Group LLC bought a new stake in Intuitive Surgical during the second quarter worth about $110,000. D. Scott Neal Inc. bought a new stake in Intuitive Surgical during the second quarter worth about $120,000. Harvest Fund Management Co. Ltd bought a new stake in Intuitive Surgical during the second quarter worth about $120,000. Finally, Parallel Advisors LLC increased its stake in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock worth $129,000 after buying an additional 14 shares during the last quarter. Institutional investors own 96.08% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.